Treatment method is directed at identification/elimination of triggers, if current, and improvement from the pores and skin barrier by way of topical creams and ointments. In the section 2 demo, six subcutaneous injections at intervals of 1-2 weeks of allergen-CpG ODN-loaded virus-like particles, when provided to individuals with allergic rhinocon